Published in Balkan J Med Genet on July 09, 2016
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics (2004) 5.12
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J (2005) 3.51
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics (2002) 3.45
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet (1997) 3.08
Moving towards individualized medicine with pharmacogenomics. Nature (2004) 2.99
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry (2004) 2.98
The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet (1989) 2.90
Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am J Hum Genet (2000) 2.25
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci U S A (1993) 2.08
CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics (2007) 1.97
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci (1999) 1.77
Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev (2006) 1.64
Pharmacogenetics - five decades of therapeutic lessons from genetic diversity. Nat Rev Genet (2004) 1.59
Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J Clin Psychopharmacol (2000) 1.51
Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics (1995) 1.39
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics (1999) 1.36
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction. Pharmacogenomics J (2008) 1.23
Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam Clin Pharmacol (2007) 1.16
Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene (1999) 1.11
Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population. Clin Pharmacol Ther (1999) 1.05
Determination of CYP2D6 gene copy number by pyrosequencing. Clin Chem (2005) 1.01
Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Croat Med J (2003) 1.01
Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective. Indian J Med Res (2014) 0.96
Genetic basis of drug metabolism. Am J Health Syst Pharm (2002) 0.95
CYP2D6 genotyping by a multiplex primer extension reaction. Clin Chem (2005) 0.95
Pharmacogenetics and the future of medical practice. Br J Clin Pharmacol (2002) 0.93
Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis. PLoS One (2011) 0.82
Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population. Cell Biochem Funct (2008) 0.81
Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia. Balkan J Med Genet (2015) 0.78
High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians. Environ Toxicol Pharmacol (2013) 0.77
Proteomic analysis of seminal plasma in men with different spermatogenic impairment. Andrologia (2012) 0.90
Genetic causes of male infertility. Balkan J Med Genet (2012) 0.81
Genetic variation of the brca1 and brca2 genes in macedonian patients. Balkan J Med Genet (2012) 0.81
Hb Jambol: a new hyperunstable hemoglobin causing severe hemolytic anemia. Acta Haematol (2006) 0.78
A Homozygous Deletion of the DPY19l2 Gene is a Cause of Globozoospermia in Men from the Republic of Macedonia. Balkan J Med Genet (2013) 0.76
Human seminal plasma proteome study: a search for male infertility biomarkers. Balkan J Med Genet (2012) 0.75
Rapid and non invasive prenatal diagnosis. Balkan J Med Genet (2012) 0.75
MicroRNAs in Breast Cancer -Our Initial Results. Balkan J Med Genet (2012) 0.75
Study of the hepatitis C virus in the republic of macedonia. Balkan J Med Genet (2012) 0.75
CAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer. Balkan J Med Genet (2012) 0.75
Hb Brockton [beta138(H16)Ala-->Pro] observed in a Chinese boy. Hemoglobin (1998) 0.75
In memoriam: Efremov D. Georgi (1932-2011). Founder of the molecular biology in the Republic of Macedonia - biochemist, geneticist. Prilozi (2011) 0.75
National Reference Centre for Genomics and Proteomics - MACPROGEN. Balkan J Med Genet (2012) 0.75
Hb Saint Etienne or Hb Istanbul [beta92(F8)His-->Gln] found in an Argentinean family. Hemoglobin (2000) 0.75
A new beta chain variant, Hb Vienna or beta77(EF1)His-->Gln. Hemoglobin (1998) 0.75
A new familial mutation (R133G) in the SRY gene. Clin Genet (2007) 0.75